Not really. That's the author's point of view. Various statements in the paper say that CSII is not better than MDI, and more importantly, excellent control is a result of "a multitude of patient characteristics and diabetes management practices"
The REPOSE study, which was an RCT between MDI and Pumps came up with a rather different conclusion, namely that there was little difference between pumps and MDI:
http://www.clinicalendocrinologynew...ections/bcc1a5dc8b9139d0c951d6bd2b929834.html
Ultimately, it's not the technology that currently generates better results, it's the person using it.